Evidence map›Paper›PMID 18784839›Full record

ArticlePloS one2008

Tumor growth decreases NK and B cells as well as common lymphoid progenitor.

John Richards, Beth McNally, Xianfeng Fang, Michael A Caligiuri, Pan Zheng, Yang Liu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. NK Cell Plasticity in Cancer.Journal of clinical medicine · 2019
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting.Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

John RichardsDepartment of Pathology, Division of Cancer Immunology, The Ohio State University Medical Center and Comprehensive Cancer Center, Columbus, Ohio, United States of America.
Beth McNally
Xianfeng Fang
Michael A Caligiuri
Pan Zheng
Yang Liu
Michigan United · USThe Ohio State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USUniversity of Michigan–Ann Arbor · US

Funding

Tumor burden and T cell immunityR01CA058033 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIU, YANG · 1992 to 2013
$3.3M
Selective Modulation of Cancer Immunity and AutoimmunityR01CA112001 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIU, YANG · 2006 to 2010
$1.3M
POSTDOCTORAL RESEARCH IN CANCER RISK REDUCTIONT32CA009542 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCALISTER, ALFRED L · 1986 to 1991
–
NCI NIH HHS P01CA9542NCI NIH HHS R01 CA058033NCI NIH HHS R01 CA112001
6 · The paper itself

Abstract

backgroundIt is well established that chronic tumor growth results in functional inactivation of T cells and NK cells. It is less clear, however, whether lymphopoeisis is affected by tumor growth. PRINCIPAL

findingsIn our efforts of analyzing the impact of tumor growth on NK cell development, we observed a major reduction of NK cell numbers in mice bearing multiple lineages of tumor cells. The decrease in NK cell numbers was not due to increased apoptosis or decreased proliferation in the NK compartment. In addition, transgenic expression of IL-15 also failed to rescue the defective production of NK cells. Our systematic characterization of lymphopoeisis in tumor-bearing mice indicated that the number of the common lymphoid progenitor was significantly reduced in tumor-bearing mice. The number of B cells also decreased substantially in tumor bearing mice. CONCLUSIONS AND SIGNIFICANCE: Our data reveal a novel mechanism for tumor evasion of host immunity and suggest a new interpretation for the altered myeloid and lymphoid ratio in tumor bearing hosts.

Indexed as

AnimalsApoptosisB-LymphocytesCell Line, TumorCytotoxicity, ImmunologicInterleukin-15Killer Cells, NaturalLymphoid Progenitor CellsLymphopoiesisMiceMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicNeoplasmsNeoplasm TransplantationInterleukin-15

Identifiers

PMID18784839
PMCPMC2527520
OpenAlexW2087514551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.